“agricultural biotechnology: genetically modified food and feed in … · 2011-10-21 · 15...
TRANSCRIPT
11
“Agricultural Biotechnology:Genetically modified food and feed in the EU”
Hearing European Economic and Social Committee
Brussels, 20 October 2011
Beat Späth, Public Affairs Manager,
Green Biotechnology, EuropaBio.
22
� 66 corporate members (Healthcare + Industrial + Agbiotech)� +7 associate members and 4 Bioregions� +22 national biotech associations = +1800 biotech SMEs
8 Green biotech member companies
EuropaBio: European Association of Biotechnology Industries
Industrial biotechnology / White – industrial proces sesHealthcare biotechnology / Red - pharmaceutical pro ductsPlant biotechnology / Green - agriculture/seeds
Contents
1. GMO Cultivation and trade2. Safety and Impacts3. Regulation & Politics4. Conclusions
44
1. GMO cultivation and trade
55
Agricultural biotechnology is being adopted at record speed around the world.
GMOs - The Global Picture
Source : LIS Consult 2011
66
High annual growth in cultivation area since introduction 1996.
2010 reality� 15.4 million farmers (90% resource-poor farmers in developing world)� 29 countries � 148 million hectares� Soy, cotton, maize, oilseeds, sugar beet
2015 predictions� 20 million GM crop farmers � 40 biotech countries� 200 million hectares of biotech crops� New product quality and stress resistance traits� New developers: China, India, Brazil� New crops: potato, rice, sugar beet, brinjal,…
GMOs – The Global Picture
Source : James, C. (2010) Global Status of Commercialized Biotech/GM Crops
77
GMOs - The Global Picture
Source : ISAAA, 2011 Rapid adoption of GM varieties.
8
Comparison 2010 GM cultivation worldwide vs. Europe
Global area of biotech crops: 148 million ha
Equivalent to more than 6 times land area of UK
EU area of biotech crops:
91,438 ha
Equivalent to less than the area
of Greater London
99
Cultivation of biotech crops in the EU
Cultivation
No cultivation yet
EU farmers are allowed to plant only 2 GM events
In the Americas farmers are allowed 25+
1010
EU heavily dependent on imported protein
Produced from EU soybeans: 0.8 mln t (2%)
Imported
soybean meal
24.1 mln t (66%)
Produced from
imported
soybeans
11.5 mln t (32%)
EU27: Soy imports and domestic = 35mlnt/year
Soy is used for animal feed particularly.
90% of imported soy is from biotech crops.
Non-GM soy becoming difficult to source.
Increasingly costly (e.g. $85/t premium.)
Source : David Green, Greenhouse Communications, Virginia
1111
2. Safety and Impacts
121212
No negative effects for health & environment
"A decade of EU-funded GMO research’’ (2001-2010)• 50 EU projects • more than 400 independent research groups• European research grants of some EUR 200 million
“EC-sponsored Research on Safety of Genetically Modified Organisms’’ (1985-2000)
“The use of more precise technology and the greater regulatory scrutiny probably makes GMOs even safer than conventional plants and foods.”
Biotechnology, and in particular GMOs, are not per se more risky than e.g. conventional plant breeding technologies
1313
Estimated benefits to EU of adoption of GM crops each year
Benefit to EU farmers if they were allowed to grow available GM crops is estimated at
€443 and €929 million each year.
Source: The impact of the EU regulatory constraint of transgenic crops on farm income; Julian Park, Ian McFarlane, Richard Phippsand Graziano Ceddia, New Biotechnology; March 2011
1414
Insect-resistant Bt maizeincreases competitiveness
� Improved crops
� Increased yields
� Increased income
� Cost savings
� Reduction of energy use
� Controlled targeting of pests
Europe record example: Spanish Farmers yield b y 10%
Worldwide 1996-2009: Farmer income $64.7 bill ion with significant, additional environmental benefits
Cumulative economic benefits:Developing countries (49%) > industrial 51%)
Source: PG Economics 2011 forthcoming
1515
Roundup Ready Soybean
� 1999: introduction of GM soybean (herbicide tol.)
� 2006: 137,000 out of 190,000 soybean ha
� Farmer advantages - 18% average yield gains
� Romania = soybean exporter
� 2007: EU accession. GM soybean disallowed
� 2010: Soybean area decreased to 44,000ha
� Romania = soybean importer
� 2008: Lost profit at farmer level: €19 million
� 2009: $137.3 million spent on imports to fulfill soy needs
GM soybeans in Romania provided economic success
Conventional Soybean
Additional GMO benefits
Produce more with less
Farmers• Higher yields• Higher sucess rate (lower crop failure)• Lower inputs (for example less ploughing, spraying)
Environment• More crops on less land: biodiversity • Less ploughing and spraying = less CO2, less soil degradation, • More efficient water use
Food security & develoment• 90% of GM farmers = resource poor, from developing countries
1717
Wealthier: India, Russia & China
Feeding the World
Today 2100
World population growth
Climate change
Water shortages
Biofuels
Increasing demand•9 billion•changing food habits•better diets•biofuel use
Decreasing capacity•Less land/ less good land•Climate change
Farmable land
Source : David Green, Greenhouse Communications, Virginia. And Economist magazine 2011.
1818
3. Regulation & Politics
191919
� Strict EU regulation
� Cultivation and imports only possible with approval
� Authorisation product by product
� EFSA safety assessment
� Political decision (comitology)
� approvals system not fundamentally different from systems elsewhere
� But minority of Member States prevent system from working properly
Regulation in the EU
_____________________________________________________________________________________________“Approvals of GMOs in the European Union”. Report av ailable from EuropaBio.
Regulation in the EU
• Authorisation system for GMOs not working as it should
• There is a significant backlog– Every year, twice as many GM products enter the system as exit it.– Almost twice as many product applications in the system, than have exited it
• EU process takes substantially longer than comparable systems
• Slow process cannot be explained by safety concerns alone– Commission takes much longer to put products to the vote than foreseen by law– New assessment requirements lacking scientific basis are introduced
• For cultivation, the agreed process has never been correctly implemented
• Some governments vote against EFSA scientific advice for political reasons
_____________________________________________________________________________________________“Approvals of GMOs in the European Union”. Report av ailable from EuropaBio.
21
Member States voting against EFSA scientific opini on
EU authorisation voting
The chart shows that 10 countries vote against the EFSA scientific opinion more than 63% of the time.
_____________________________________________________________________________________________“Approvals of GMOs in the European Union”. Report av ailable from EuropaBio.
Status end 2010• 101 products submitted to the EU authorisation system
• 36 products approved
• 65 products in the EU authorisation system (8 new submissions in 2011, actual total now 73)
Prediction for 2015• 20 individual new events • 4 renewals
• 22 stacked events
• 12 events developed for local markets, not seeking an approval in the EU
Forward projection
93 products in the system in 2015 (assuming average 6 approvals per year)68 products in the system in 2015 (assuming average 11 approvals per year)
EVEN IF THE APPROVAL RATE ALMOST DOUBLES THE BACKLOG REMAINS UNCHANGED
_____________________________________________________________________________________________“Approvals of GMOs in the European Union”. Report av ailable from EuropaBio.
Conclusions on EU approvals
If the EU continues down its present path – trade problems will increase– farmers will continue to lose out and become increasingly uncompetitive– political pressure will increase– public acceptance will continue to suffer
The biotech industry and EU decision-makers alike a gree that– legislation must be properly implemented– confidence in the system must be restored
EU needs a clear, consistent and science-based poli cy approach– safeguard EFSA’s independence rather than undermine it– promote science and separate it clearly from politics– resist unscientific concessions, that undermine credibility, for short-term political
gains
Efficiency gains are possible without impacting tho roughness, completeness or independence of assessment
2424
4. Conclusions
Conclusions
GMOs in agriculture: • Fasted adopted agricultural technology in history
• Economic benefits: 15 million farmers can’t be wrong
• Unparalleled safety record• Environmental benefits
EU & GMOs: • Limited cultivation, but massive imports (60 kg pa per citizen)
• Strict regulation: fact based in theory but political in practice
Political questions: is it justifyable...• ... to import but not to grow?
• ... to ban safe products from the market? • ... for the EU not to contribute to global food security?
2626
Thank you for your attention! Questions?
Beat Späth, Public Affairs Manager,
Green Biotechnology, EuropaBio.